Original language | English |
---|---|
Pages (from-to) | 1449 |
Number of pages | 1 |
Journal | Annals of Oncology |
Volume | 25 |
Issue number | 7 |
DOIs |
|
State | Published - Jul 2014 |
Corrigendum to A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma [AnnOncol 2013, 24, 3076-3081] doi: 10.1093/annonc/mdt414
A. M. Evens, K. R. Carson, J. Kolesar, C. Nabhan, I. Helenowski, N. Islam, B. Jovanovic, P. M. Barr, P. F. Caimi, S. A. Gregory, L. I. Gordon
Research output: Contribution to journal › Comment/debate